Red cell pyruvate kinase deficiency. The effect of splenectomy
T. F. Necheles
Abstract
T. F. Necheles
Abstract
THE DEFICIENCY of the enzyme pyruvate kinase (PK) in the human erythrocyte is associated with the group of congenital nonspherocytic hemolytic anemias formerly classified as type II by the autohemolysis test of Dacie.1Erythrocytes from such patients exhibit marked autohemolysis when incubated in saline which is not corrected by the addition of glucose but is usually corrected in the presence of adenosine triphosphate (ATP). More than 60 patients with this enzyme deficiency have been described in the three years since its discovery by Tanaka et al.2No therapy has been reported to be of general benefit. The purpose of this paper is to describe two further cases, emphasizing the beneficial effects of splenectomy and the marked variability of the clinical course in this genetic deficiency. Methods Hematologic studies were carried out using standard techniques. Autohemolysis studies on erythrocytes were performed as published by Dacie.1Pyruvate kinase activity of the erythrocytes
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
THE DEFICIENCY of the enzyme pyruvate kinase (PK) in the human erythrocyte is associated with the group of congenital nonspherocytic hemolytic anemias formerly classified as type II by the autohemolysis test of Dacie.1Erythrocytes from such patients exhibit marked autohemolysis when incubated in saline which is not corrected by the addition of glucose but is usually corrected in the presence of adenosine triphosphate (ATP). More than 60 patients with this enzyme deficiency have been described in the three years since its discovery by Tanaka et al.2No therapy has been reported to be of general benefit. The purpose of this paper is to describe two further cases, emphasizing the beneficial effects of splenectomy and the marked variability of the clinical course in this genetic deficiency. Methods Hematologic studies were carried out using standard techniques. Autohemolysis studies on erythrocytes were performed as published by Dacie.1Pyruvate kinase activity of the erythrocytes
Key concepts: Pyruvate kinase deficiency, Pyruvate kinase, Splenectomy, Red Cell, Enzyme, Adenosine triphosphate, Red blood cell, Chemistry